332 related articles for article (PubMed ID: 34021503)
1. Papillary thyroid microcarcinoma: Is active surveillance always enough?
Sutherland R; Tsang V; Clifton-Bligh RJ; Gild ML
Clin Endocrinol (Oxf); 2021 Dec; 95(6):811-817. PubMed ID: 34021503
[TBL] [Abstract][Full Text] [Related]
2. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
3. Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan.
Sugitani I; Ito Y; Miyauchi A; Imai T; Suzuki S
Thyroid; 2019 Nov; 29(11):1563-1571. PubMed ID: 31441377
[No Abstract] [Full Text] [Related]
4. Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases.
Medas F; Canu GL; Cappellacci F; Boi F; Lai ML; Erdas E; Calò PG
Front Endocrinol (Lausanne); 2020; 11():551. PubMed ID: 32982963
[No Abstract] [Full Text] [Related]
5. Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea.
Oh HS; Ha J; Kim HI; Kim TH; Kim WG; Lim DJ; Kim TY; Kim SW; Kim WB; Shong YK; Chung JH; Baek JH
Thyroid; 2018 Dec; 28(12):1587-1594. PubMed ID: 30226447
[TBL] [Abstract][Full Text] [Related]
6. [Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data].
Pelizzo MR; Merante Boschin I; Toniato A; Piotto A; Bernante P; Pagetta C; Casal Ide E; Mazzarotto R; Casara D; Rubello D
Minerva Chir; 2007 Oct; 62(5):315-25. PubMed ID: 17947943
[TBL] [Abstract][Full Text] [Related]
7. Active Surveillance for Papillary Thyroid Microcarcinoma in a Population with Restrictive Diagnostic Workup Strategies.
Lončar I; van Dijk SPJ; Metman MJH; Lin JF; Kruijff S; Peeters RP; Engelsman AF; van Ginhoven TM
Thyroid; 2021 Aug; 31(8):1219-1225. PubMed ID: 33430696
[No Abstract] [Full Text] [Related]
8. Active surveillance of low-risk papillary thyroid microcarcinomas in Japan and other countries: a review.
Ito Y; Miyauchi A
Expert Rev Endocrinol Metab; 2020 Jan; 15(1):5-12. PubMed ID: 31902250
[No Abstract] [Full Text] [Related]
9. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A
Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426
[No Abstract] [Full Text] [Related]
10. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
[TBL] [Abstract][Full Text] [Related]
11. [Progress in active surveillance for adult low-risk papillary thyroid microcarcinoma].
Liu J; Xu C; Yao X; Zhao R; Zhang S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Feb; 37(2):150-156. PubMed ID: 36756834
[No Abstract] [Full Text] [Related]
12. Extensive lymphatic spread of papillary thyroid microcarcinoma is associated with an increase in expression of genes involved in epithelial-mesenchymal transition and cancer stem cell-like properties.
Lee S; Bae JS; Jung CK; Chung WY
Cancer Med; 2019 Nov; 8(15):6528-6537. PubMed ID: 31498560
[TBL] [Abstract][Full Text] [Related]
13. Comparison of clinicopathological features and prognosis of papillary thyroid carcinoma and microcarcinoma: A population-based propensity score matching analysis.
Qian B; Hu L; Zhang S; Zhu J; Mei L; Huang T; Qu X
Front Endocrinol (Lausanne); 2022; 13():944758. PubMed ID: 35992148
[TBL] [Abstract][Full Text] [Related]
14. Active Surveillance of Thyroid Microcarcinomas: a Critical View.
Cernea CR; Matos LL; Eugênio C; Ferreira GM; Cerqueira YS; Leite AKN; Vanderlei FAB; de Carlucci D; Gotoda RN; Hojaij FC; Araújo-Filho VJF
Curr Oncol Rep; 2022 Jan; 24(1):69-76. PubMed ID: 35061193
[TBL] [Abstract][Full Text] [Related]
15. Overview on surgical management of papillary thyroid microcarcinoma.
Ruggiero R; Pirozzi R; Gualtieri G; Terracciano G; Parisi S; Nesta G; Gazeneo L; Lanza Volpe M; Rinaldi S; Docimo L
G Chir; 2019; 40(2):81-87. PubMed ID: 31131805
[TBL] [Abstract][Full Text] [Related]
16. [Current treatment strategies for papillary thyroid microcarcinoma].
Weber T
Chirurg; 2020 Dec; 91(12):994-998. PubMed ID: 32776249
[TBL] [Abstract][Full Text] [Related]
17. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
[TBL] [Abstract][Full Text] [Related]
18. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.
Vasileiadis I; Karatzas T; Vasileiadis D; Kapetanakis S; Charitoudis G; Karakostas E; Kouraklis G
Head Neck; 2014 Apr; 36(4):564-70. PubMed ID: 23780707
[TBL] [Abstract][Full Text] [Related]
20. Protocol for a Korean Multicenter Prospective Cohort Study of Active Surveillance or Surgery (KoMPASS) in Papillary Thyroid Microcarcinoma.
Jeon MJ; Kang YE; Moon JH; Lim DJ; Lee CY; Lee YS; Kim SW; Kim MH; Kim BH; Kang HC; Shong M; Cho SW; Kim WB
Endocrinol Metab (Seoul); 2021 Apr; 36(2):359-364. PubMed ID: 33752303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
